GPT and tuberculosis: Concurrent oral administration of either SILY or two doses of MLEO significantly decreased (p < 0.001) the elevated levels of serum ALP, ALT, AST, LDH, GGT, total cholesterol, triglycerides, LDL-Chol., vLDL-Chol., urea, uric acid, and creatinine as well as cardiac risk indices I and II when compared with the anti-TB drug mixture (INH/RIF/PZA) group.